Suzanne Ildstad, Director at Talaris Therapeutics, Inc. (TALS), sold 29 shares at $2.05 ($59) on 2023-03-01, disclosed to the SEC on 2023-03-02.
Open-market sale of $59 TALS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TALS | SELL | 2023-06-07 | $149K | — | Filing → |
| TALS | SELL | 2023-06-05 | $80K | — | Filing → |
| TALS | SELL | 2023-04-25 | $35K | — | Filing → |